Everything You Need, All in One Place
From essential pharmaceuticals to capital equipment and supply chain solutions, we deliver with the speed and flexibility your facility depends on.
By forming partnerships and consulting with experts from around the world, Max-Brom London Pharmaceutical established the basis for achieving excellence. We followed global standards of quality, shaping their path to success. Max-Brom London Pharmaceutical didn't just produce capsules. We sought to revolutionize the healthcare industry, one capsule at a time. From unprecedented situations like the COVID-19 pandemic to the ongoing aging of the global population, there are numerous pressing medical needs today that require the expertise of biomedical science professionals.
Max-Brom London Pharmaceutical's founding was an important step towards improving local healthcare in the United Kingdom. As early as 1985, Max-Brom London Pharmaceutical established its operations in London and undertook three significant projects that laid the groundwork for quality healthcare provision. Various production lines, including Solid Tablets, Capsules, and Oral Syrups, were also installed in our facility, which stood as a symbol of hope and health for the region.
For over 25 years, Max-Brom London Pharmaceutical has partnered with biotech, pharmaceutical, and medical device organizations to bring groundbreaking therapies to market. Offering a fully customizable, end-to-end suite of services, we empower our clients to overcome regulatory complexities and deliver life-changing therapies to patients worldwide.
Comprehensive Services Across All Phases
Max-Brom Pharmaceutical delivers comprehensive services across all phases of the product lifecycle, from early development to post-market support. Our integrated solutions ensure seamless navigation through regulatory, clinical, and compliance challenges, empowering life sciences organizations to bring innovative therapies to patients with confidence.
Expertise That Delivers Results
With expertise across regulatory sciences, clinical research, compliance, pharmacovigilance, and medical information, our team provides strategic guidance tailored to every challenge. We partner with clients to deliver innovative solutions that ensure success throughout the entire product lifecycle.
Full-Service Capabilities
With global reach and scale, Max-Brom Pharmaceutical offers an end-to-end suite of bespoke solutions to ensure its clients have access to robust expertise and extensive consulting resources across the full product lifecycle. Our team of experts and strategists possess the knowledge and skillsets to support global clients at every development stage.
Clinical Pharmacovigilance
The early stages of a clinical program can be costly, trying to determine the services to trim down and where to really invest. Our solution is a simple yet scalable model starting with the basics: a safety database that can go the distance from clinical studies into post-marketing, a project team that is trained to understand the safety profile of the product and the sponsor’s motivations, and sound regulatory intelligence to navigate the guidances and requirements.
As the global reach and the complexity of the program grows, so too do the possible services, including literature search and review, custom database reports, or signal management. We share your cost concerns and have created options for many of our services from database access to Global Safety Plans—each with different price tags depending on the level of service chosen. You want to choose where to trim down and where to invest, and we want to help.
The Pharmacovigilance System Master File (PSMF) describes the PV system of the Marketing Authorization Holder (MAH) and is a legal requirement for MAHs to maintain and make available to Health Authorities .
Our team of clinical research experts brings depth and breadth of experience across all phases of clinical trials, applying proven techniques to provide innovative solutions. Regardless of where you are in the product lifecycle or what your clinical trial–related needs are, we offer clinical research solutions to efficiently bring your product to market. With decades of industry experience, our team of clinical research experts is current with the latest industry intelligence and ever-evolving regulations, making Max-Brom London Pharmaceutical the partner of choice when outsourcing your clinical trials. Our clinical research experts offer solutions to bring your product to market, regardless of where you are in your product’s lifecycle.The path to project success begins with choosing the right model and methodology to anticipate and manage the challenges that could arise during the lifecycle of a clinical trial.. We will work with you to develop strategic, flexible approaches that leverage technology, clinical informatics, and our global reach to maximize data‑driven decision making that drives safety, quality, and efficiency.
At Max-Brom London Pharmaceutical, our expansive team of consultants and subject matter experts support a diverse spectrum of products, including drugs, biologics, medical devices, and diagnostics. Our dedicated team of experts specializes in providing comprehensive solutions tailored to the unique technical and quality requirements of each product category. Whether you are embarking on the development journey for your first drug or biologic, or you are an established company in the device and diagnostics sector, we have the expertise to guide you through the complexities of ensuring product integrity and reliability.
The development paths for drugs, biologics, medical devices, and diagnostics vary significantly, each presenting its own set of technical challenges and quality considerations. At Max-Brom London Pharmaceutical, we understand the critical importance of maintaining rigorous quality standards and ensuring GxP compliance throughout the product lifecycle. With our expertise in quality assurance, validation, and regulatory compliance, we can assist you in navigating the intricate technical landscape with confidence.
Clinical operations play a pivotal role in the successful execution of clinical research, encompassing the design, implementation, and management of Phase I to IV trials.
With the increasing complexity of clinical trials, driven by heightened regulatory guidelines, the pressure on clinical operations teams has intensified. While some organizations allocate considerable time and resources to this aspect, others opt to outsource their clinical trials to Contract Research Organizations (CROs) specializing in the specific field of research. These CROs offer comprehensive services, ensuring end-to-end support for the seamless execution of trials. Our dedicated clinical operations team collaborates with you to optimize the design of your clinical trials, implement patient-centric approaches, and provide guidance throughout the entire clinical development lifecycle. Discover how our experts can assist you in the multi-phase development of your clinical operations.
Global Clinical Trial Management Teams
Global footprint, local expertise: we provide the flexibility you need in a rapidly evolving environment. Our experienced teams offer the footprint to meet your local clinical trial needs, with the confidence and agility to globalize when you are ready. Our global governance structure streamlines the complexity of multi-region studies.
Data Safety Monitoring Board
Data Safety Monitoring Board (DSMB) services provide you with improved workflows, compliance, and communication to ensure the safety and integrity of your clinical study data.
Max-Brom London Pharmaceutical’s team of medical consultants provides the option of safety data review (i.e., individual case safety reports and/or aggregate summaries of data) by a physician with experience in pharmacovigilance.
Max-Brom London Pharmaceutical’s Medical Writing teams create best-in-class quality documents to support all elements of your clinical trial needs, from protocol and consent forms, Investigator’s Brochures, clinical study reports, patient narratives, and CTD Module documents, to registering and disclosing clinical trial information on public registries and redacting documents to meet commercial transparency obligations while protecting patient and company confidentiality.
Our world-class Biostatistics and Data Management teams and programmers are adept at creating and managing quality design, build, and outputs. They will partner with you to ensure you achieve the most robust and successful outcomes, incorporating unique and adaptive designs where best suited.
Global pharmacovigilance specialists and medical monitors are here to support the safe implementation of your studies and provide expert guidance, reporting, and DSMB management. We have a range of disease and therapy area experts to ensure you have the best, contemporary advice.
Decentralized Clinical Trials
Decentralized Clinical Trials (DCTs) are studies that are designed for study visits, procedures, and data collection to occur outside of the traditional site setting. DCTs revolve around the concept of patient centricity, intending to make participation easier and more convenient for the patient, ultimately creating a larger, more diverse population to test your drug or device while ensuring patient comfort and safety. The increased flexibility of DCTs expands the geographical reach, improves recruitment and retention, and enhances the patient experience while providing Sponsors with reliable data.
We support DCTs by providing the opportunity for study visits to take place in a location convenient to the patient, such as their home or office, supported by our team of employee GoClinical Clinicians who are trained in GCP and protocol-specific procedures.
Home Visits
It can be overwhelming to determine how to deploy a decentralized approach, so incorporating home visits into your protocol is often a great place to start. Max-Brom London Pharmaceutical can support home visits as part of a hybrid or completely virtual trial design. Home visits allow for greater flexibility in your study design and reduce the burden of participation on the patient by designing processes that fit into the patient’s life, rather than asking the patient to fit their life into the trial. Allowing simple procedures to be performed in the patient’s home also reduces the burden on the site by allowing site staff to focus on recruiting and enrolling patients and more complex procedures..
Employee Nursing Staff
Max-Brom London Pharmaceutical directly employs all GoClinical Clinicians (GCCs) to support your patients. Once hired, all GCCs are overseen by our Director of DCT Nursing and receive extensive training in GCP, IATA (Dangerous Goods), and protocol-specific procedures. This allows us to have direct oversight of all visits and ensures those visits are performed by known, high-quality clinicians with strong clinical skills and trial experience. GCCs are selected based on study requirements and range from phlebotomists, LPNs, and RNs. We are easily able to add GCCs based on location by leveraging an extensive Global Talent Acquisition team and sister staffing companies, with over 25,000 qualified providers currently in our global database. Our approach reduces sponsor costs, removes unnecessary layers of vendor administration, and alleviates the challenges of finding providers on short notice through local home health agencies, significantly reducing the risk of missed visits.
Experience and Global Reach
Max-Brom London Pharmaceutical has invested in hiring the best leaders within the Decentralized Clinical Trial (DCT) space to build out the most efficient operational strategy based on lessons learned from several years of experience. As the decentralized approach grows in the clinical research space, it is becoming even more important for Sponsors to have a reliable partner that can assist in designing trials with decentralized approaches in mind. Our DCT leadership team has over 10 years of experience in the DCT space and can help your team design and implement the right DCT solutions for your trial. Whether you’re interested in hybrid or completely virtual clinical trials, our team of experts can help.
Max-Brom London Pharmaceutical has 27 offices & affiliates worldwide spanning 6 continents, providing a truly global footprint to support your decentralized clinical trials. Max-Brom London Pharmaceutical has over 25 years of experience supporting Sponsors from early development through commercialization, which allows for expert insight at any phase or function of your study and a streamlined approach from a single provider.
Embedded Solutions
Our team of project leaders and clinical subject matter practitioners can support you in your journey to successfully deliver projects, achieve critical outcomes, and realize or improve efficiencies. Whether you are looking for an expert to provide advisory services or several cross-disciplinary personnel our solutions-focused approach will add value to your organization.
Specialized Project-Based Services
Our team of qualified consultants applies proven and proprietary project management methodologies to help you successfully develop and launch products to market safely and quickly. By focusing on your desired outcomes, we take time to thoroughly plan the solution. We have done these projects before and understand the functional dependencies that can impact the plans, and know what works.
In-Depth Expertise
Our team of clinical experts brings leadership to your projects to help you complete your important, complex projects regardless of where your team is in the clinical development process. We help you make decisions quickly and achieve outcomes.
Cynthia Anderson
Global Head, Clinical Operations
Naomi McPhillips
Global Head, Clinical Data Science
Jennifer Hills
Vice President, Decentralized Clinical Trials